semaglutide alzheimer's clinical trial Two of the most anticipated studies this year—large-scale, randomized, controlled, and double-blinded trials of the popular obesity and diabetes drug for disease—have unfortunately ended in a dud. An oral version Alzheimer's trial exposes GLP-1 limits
Description
Therapeutic roles of curcumin: lessons learned from clinical trials
We've helped countless patients look, live and feel better
Int J Sport Nutr Exerc Metab
diabetes indications are generally better covered than obesity indications for both medications
